BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights: Strategic Trials and ...

By Yahoo! Finance | Nov 15, 2024 at 02:11 AM EST

Rescue medications are allowed in the SERENITY study as a safety measure to track inefficacy for patients on placebo. FDA feedback on the TRANQUILITY trial protocol was deemed satisfactory. The company is focused on strengthening its balance sheet and partnership opportunities through ongoing trials.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.